Metraipolis › archive › dc_ca408f3b792e

Predictors of Dual Phosphodiesterase Type 5 Inhibitor Therapy in Persons With Erectile Dysfunction and Diabetes — Europe PMC PMID:41054657

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41054657
DOI
10.7759/cureus.91566
License (as archived)
solo-consultazione
Archived
2026-11-10T03:23:38.429Z
SHA-256 of the archived text
1cf491d0a67c8e8b5a7af0fee4fc4ef74c573652547d8406dc4c1d4777db9603
Stable URL of this page
https://metraipolis.com/documento/dc_ca408f3b792e

How to cite

Predictors of Dual Phosphodiesterase Type 5 Inhibitor Therapy in Persons With Erectile Dysfunction and Diabetes — Europe PMC PMID:41054657 — Europe PMC (en), https://europepmc.org/article/MED/41054657 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ca408f3b792e (Metraipolis archive dc_ca408f3b792e, sha256 1cf491d0a67c8e8b5a7af0fee4fc4ef74c573652547d8406dc4c1d4777db9603)
BibTeX
@misc{dcca408f3b792e,
  title = {Predictors of Dual Phosphodiesterase Type 5 Inhibitor Therapy in Persons With Erectile Dysfunction and Diabetes — Europe PMC PMID:41054657},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41054657},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ca408f3b792e; sha256 1cf491d0a67c8e8b5a7af0fee4fc4ef74c573652547d8406dc4c1d4777db9603},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41054657. Agents can read the archived copy with the MCP tool read_document.